Oseltamivir vs Pembrolizumab

## Oseltamivir vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Oseltamivir** and **Pembrolizumab**.

## Mechanism of Action

**Oseltamivir**: Neuraminidase inhibitor preventing viral release from host cells.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Oseltamivir — 6-10 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Oseltamivir — C16H28N2O4; Pembrolizumab — N/A.

**Molecular Weight**: Oseltamivir — 312.4050 g/mol; Pembrolizumab — N/A.

**Type**: Oseltamivir — Small molecule; Pembrolizumab — Antibody.